Questions for 9/5/17

Questions for 9/5/2017

1. What other ways can pharmaceutical companies extend their patents?

2. What drugs are considered biological drugs? And why do they have a stronger patent protection?

3. What is the success rates for new drugs entering the market?

4. How well do advertised drugs do vs  do better than non advertised?

Comments

Post a Comment

Popular posts from this blog

Questions for 10/3

1. What pricing strategies are used to calculate what a drug costs to the consumer? 2.  I read in my industry report that biologics have a longer shelf life than traditional drugs, which makes them more and more favorable to produce for patent reasons. Why do biologics have a longer shelf life? Is there a chemical component? 3. How has the packaging requirements for pharmaceuticals changed ever since the Tylenol incident of the 80's? 4. What does say, CVS do with expired drugs on the shelves? Do they throw them away? Or do they send them back to the company for any rebates? And how does the company dispose of them?
Read more

What I learned week 5

There were several things this week that I learned about clinical trials and drug development, as well as how to take this knowledge and impress future businesses I apply to with terminology I've learned. The biggest thing career wise I learned this week is to really stay current with what's happening within the pharmaceutical world. This mean reading articles, even subscribing to pharmaceutical magazines. This also means getting to know the companies I plan to apply too. Knowing about the culture of a company is very important, because it directs how they do business. Dr. Priefer acknowledged that if you can throw out some terms when on an interview such as LD50, the amount of an ingested substance that kills 50 percent of a test sample, for example, this already puts you ahead of the other applicants because its shows you understand the drug development process and a general knowledge of how things work; even if you know just the basics. So that takes care of the caree...
Read more

What I learned week 16

This week was our final class as well as our final presenter, Beth Schively, Marketing Director of Scapa Healthcare and a graduate of WNE. I’ve heard Beth speak before at a pharmaceutical business luncheon, so I had a little knowledge about what she did and who she worked for. Scapa is a global strategic outsource partner of turn-key, skin friendly adhesive solutions for the healthcare industry. Scapa Healthcare partners with market leaders to design, develop, manufacture and commercialize innovative medical device products. One of Scapa’s competitive advantages is that they will not compete with their partners. Scapa does not sell to the end consumer, they work directly business to business. Their biggest competitor 3M does compete with its partners because they’ll bring their competitors adhesives to market, as well as their own. Both products could be side by side on the shelf. Scapa sees this as a plus for them because their customers feel like they aren’t being cheated. Beth ...
Read more